MiMedx Group, Inc. (NASDAQ: MDXG) reported Q2 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.22 million.

For earnings history and earnings-related data on MiMedx Group, Inc. (MDXG) click here.